256 related articles for article (PubMed ID: 7526641)
21. Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome.
Butterfield JH
J Allergy Clin Immunol Pract; 2023 Aug; 11(8):2542-2546. PubMed ID: 36863614
[TBL] [Abstract][Full Text] [Related]
22. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
[TBL] [Abstract][Full Text] [Related]
23. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
Ravi A; Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation.
Toru H; Eguchi M; Matsumoto R; Yanagida M; Yata J; Nakahata T
Blood; 1998 Jan; 91(1):187-95. PubMed ID: 9414284
[TBL] [Abstract][Full Text] [Related]
25. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
26. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
Schwartz LB; Metcalfe DD; Miller JS; Earl H; Sullivan T
N Engl J Med; 1987 Jun; 316(26):1622-6. PubMed ID: 3295549
[TBL] [Abstract][Full Text] [Related]
27. Immunologic and non-immunologic release of histamine and tryptase from human heart mast cells.
Patella V; Marinò I; Lamparter B; Genovese A; Adt M; Marone G
Inflamm Res; 1995 Apr; 44 Suppl 1():S22-3. PubMed ID: 8520982
[No Abstract] [Full Text] [Related]
28. The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reaction in the skin.
Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT
Clin Exp Allergy; 2001 Apr; 31(4):593-601. PubMed ID: 11359428
[TBL] [Abstract][Full Text] [Related]
29. Serum tryptase and the laboratory diagnosis of systemic mastocytosis.
Schwartz LB; Irani AM
Hematol Oncol Clin North Am; 2000 Jun; 14(3):641-57. PubMed ID: 10909044
[TBL] [Abstract][Full Text] [Related]
30. Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase.
Brockow K; Akin C; Huber M; Scott LM; Schwartz LB; Metcalfe DD
J Allergy Clin Immunol; 2002 Jan; 109(1):82-8. PubMed ID: 11799370
[TBL] [Abstract][Full Text] [Related]
31. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
32. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
Theoharides TC; Boucher W; Spear K
Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
[TBL] [Abstract][Full Text] [Related]
33. Mast cell tryptase potentiates histamine-induced contraction in human sensitized bronchus.
Johnson PR; Ammit AJ; Carlin SM; Armour CL; Caughey GH; Black JL
Eur Respir J; 1997 Jan; 10(1):38-43. PubMed ID: 9032489
[TBL] [Abstract][Full Text] [Related]
34. Human mast cell tryptase in biology and medicine.
Vitte J
Mol Immunol; 2015 Jan; 63(1):18-24. PubMed ID: 24793463
[TBL] [Abstract][Full Text] [Related]
35. Mast cell activation in arthritis: detection of alpha- and beta-tryptase, histamine and eosinophil cationic protein in synovial fluid.
Buckley MG; Walters C; Wong WM; Cawley MI; Ren S; Schwartz LB; Walls AF
Clin Sci (Lond); 1997 Oct; 93(4):363-70. PubMed ID: 9404229
[TBL] [Abstract][Full Text] [Related]
36. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone.
Baghestanian M; Bankl Hc; Sillaber C; Beil WJ; Radaszkiewicz T; Füreder W; Preiser J; Vesely M; Schernthaner G; Lechner K; Valent P
Leukemia; 1996 Jan; 10(1):159-66. PubMed ID: 8558922
[TBL] [Abstract][Full Text] [Related]
37. Mast cell tryptase in dermal neurogenic inflammation.
Schmelz M; Zeck S; Raithel M; Rukwied R
Clin Exp Allergy; 1999 May; 29(5):695-702. PubMed ID: 10231325
[TBL] [Abstract][Full Text] [Related]
38. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
39. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
40. [Tryptase: a diagnostic marker in allergic diseases].
Martínez Infante E; Rojas Ramos E; Orea Solano M
Rev Alerg Mex; 1996; 43(3):73-6. PubMed ID: 8963645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
